Igor Y Pavlov

Summary

Affiliation: ARUP Institute for Clinical and Experimental Pathology
Country: USA

Publications

  1. pmc High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides
    Marshall E Kadin
    Department of Dermatology, Boston University, Roger Williams Medical Center, Providence, Rhode Island 02908, USA
    J Invest Dermatol 132:703-10. 2012
  2. doi Resampling model of the complement component functional assay: Are we measuring what we think we are measuring?
    Igor Y Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84108, United States
    Clin Chim Acta 421:87-90. 2013
  3. doi Reference interval computation: which method (not) to choose?
    Igor Y Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA
    Clin Chim Acta 413:1107-14. 2012
  4. ncbi Urine TGF- beta1 assay validation: spinning down urine samples could diminish TGF-beta1 signal
    Igor Y Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA
    Clin Lab 57:1027-9. 2011
  5. pmc Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing
    Igor Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Clin Vaccine Immunol 16:1327-31. 2009
  6. pmc Resampling approach for determination of the method for reference interval calculation in clinical laboratory practice
    Igor Y Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, 500 Chipeta Way, Salt Lake City, UT 84108, USA
    Clin Vaccine Immunol 17:1217-22. 2010
  7. ncbi Specificity of EIA immunoassay for complement factor Bb testing
    Igor Y Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA
    Clin Lab 57:225-8. 2011
  8. pmc Identification and validation of shrimp-tropomyosin specific CD4 T cell epitopes
    Eugene V Ravkov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84108, United States Electronic address
    Hum Immunol 74:1542-9. 2013
  9. doi Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study
    Julio C Delgado
    Department of Pathology, ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City, UT 84108, United States
    Transpl Immunol 22:1-4. 2009
  10. pmc Validation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplant
    Eugene V Ravkov
    Department of Pathology, ARUP Institute for Clinical and Experimental Pathology, School of Medicine, University of Utah, 500 Chipeta Way, Salt Lake City, UT 84108, USA
    Clin Dev Immunol 2012:451059. 2012

Collaborators

Detail Information

Publications12

  1. pmc High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides
    Marshall E Kadin
    Department of Dermatology, Boston University, Roger Williams Medical Center, Providence, Rhode Island 02908, USA
    J Invest Dermatol 132:703-10. 2012
    ..We conclude that (1) neoplastic cells of some CD30CLPD patients do not resemble Th2 cells, and that (2) high serum sCD30, sCD25, IL-6, and perhaps IL-8 levels may provide prognostic information useful for patient management...
  2. doi Resampling model of the complement component functional assay: Are we measuring what we think we are measuring?
    Igor Y Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84108, United States
    Clin Chim Acta 421:87-90. 2013
    ..To verify that such assay does actually measure functional activity of that component, authors introduced the simple resampling model of the functional test...
  3. doi Reference interval computation: which method (not) to choose?
    Igor Y Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA
    Clin Chim Acta 413:1107-14. 2012
    ..If there are no reliable RI data available, there is no way to confirm which method generates results closest to the true RI...
  4. ncbi Urine TGF- beta1 assay validation: spinning down urine samples could diminish TGF-beta1 signal
    Igor Y Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA
    Clin Lab 57:1027-9. 2011
    ..TGF-beta1 is a mediator of immune and anti-inflammatory responses. The present research was dedicated to the validation of the urine Quantikine Human TGF-beta1 ELISA assay...
  5. pmc Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing
    Igor Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Clin Vaccine Immunol 16:1327-31. 2009
    ....
  6. pmc Resampling approach for determination of the method for reference interval calculation in clinical laboratory practice
    Igor Y Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, 500 Chipeta Way, Salt Lake City, UT 84108, USA
    Clin Vaccine Immunol 17:1217-22. 2010
    ..The resampling approach could help compare different RI calculation methods. An algorithm showing a resampling procedure for choosing the appropriate method for RI calculations is included...
  7. ncbi Specificity of EIA immunoassay for complement factor Bb testing
    Igor Y Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA
    Clin Lab 57:225-8. 2011
    ..Lack of information on Bb assay cross-reactivity stimulated the authors to investigate this issue...
  8. pmc Identification and validation of shrimp-tropomyosin specific CD4 T cell epitopes
    Eugene V Ravkov
    ARUP Institute for Clinical and Experimental Pathology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84108, United States Electronic address
    Hum Immunol 74:1542-9. 2013
    ..CD4 T cell responses play an important role in the pathophysiological mechanisms of sensitization and in production of IgE...
  9. doi Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study
    Julio C Delgado
    Department of Pathology, ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City, UT 84108, United States
    Transpl Immunol 22:1-4. 2009
    ..Levels of sCD30 represent a biomarker for early outcome in kidney transplantation. The purpose of this study was to determine the role of sCD30 levels for prediction of graft loss in the late post-transplant period...
  10. pmc Validation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplant
    Eugene V Ravkov
    Department of Pathology, ARUP Institute for Clinical and Experimental Pathology, School of Medicine, University of Utah, 500 Chipeta Way, Salt Lake City, UT 84108, USA
    Clin Dev Immunol 2012:451059. 2012
    ..Our results provide acceptable measures of test performance for CMV immune competence assays for the characterization of CD8(+) T cell responses posttransplant measured in the absolute cell count per μL of blood...
  11. pmc Penaeus monodon tropomyosin induces CD4 T-cell proliferation in shrimp-allergic patients
    Shuping Wang
    Department of Dermatology, University of Utah, Salt Lake City, Utah, USA
    Hum Immunol 73:426-31. 2012
    ..These studies suggest a strategy for immunotherapy using a tropomyosin-derived T-cell epitope vaccination...
  12. doi Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern
    Eduardo Reyes-Vargas
    Department of Pathology, University of Utah, Salt Lake City, Utah 84112, USA
    J Clin Lab Anal 23:157-60. 2009
    ....